FibroGen, Inc

Historical 13F Holders

Symbol
FGEN
CUSIP
31572Q808
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 31572Q808 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Armistice Capital, LLC 13G/A
Amended under CUSIP 107930208 on 8/15/2025
8.4% 5/15/2025
Event 3/31/2025
Primecap Management Co/CA/ 13G/A 4.6% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 1 15.0 k $79.5 k
2025 Q1 61 33.0 M $10.2 M
2024 Q4 78 37.4 M $19.7 M
2024 Q3 79 47.6 M $19.5 M
2024 Q2 115 57.1 M $50.9 M
2024 Q1 122 62.2 M $147 M
2023 Q4 111 71.2 M $63.1 M
2023 Q3 122 68.4 M $59.0 M
2023 Q2 195 76.4 M $208 M
2023 Q1 190 76.4 M $1.43 B
2022 Q4 161 79.2 M $1.27 B
2022 Q3 166 73.3 M $954 M
2022 Q2 163 70.9 M $749 M
2022 Q1 172 68.0 M $817 M
2021 Q4 182 66.8 M $942 M
2021 Q3 179 64.1 M $657 M
2021 Q2 207 67.7 M $1.80 B
2021 Q1 212 71.2 M $2.47 B
2020 Q4 242 72.6 M $2.69 B
2020 Q3 232 68.9 M $2.84 B
2020 Q2 214 67.4 M $2.73 B
2020 Q1 211 64.8 M $2.25 B
2019 Q4 235 62.5 M $2.68 B
2019 Q3 228 60.9 M $2.25 B
2019 Q2 216 61.8 M $2.79 B
2019 Q1 245 58.1 M $3.16 B
2018 Q4 221 57.7 M $2.67 B
2018 Q3 206 57.8 M $3.51 B
2018 Q2 205 65.1 M $4.07 B
2018 Q1 208 54.1 M $2.50 B
2017 Q4 203 50.9 M $2.67 B
2017 Q3 196 48.2 M $2.59 B
2017 Q2 160 37.9 M $1.23 B
2017 Q1 154 31.2 M $771 M
2016 Q4 149 31.1 M $667 M
2016 Q3 142 30.8 M $637 M
2016 Q2 151 31.7 M $519 M
2016 Q1 145 32.9 M $699 M
2015 Q4 146 31.9 M $974 M
2015 Q3 123 30.2 M $679 M
2015 Q2 98 25.2 M $592 M
2015 Q1 76 16.1 M $500 M
2014 Q4 66 15.8 M $426 M